Dags att slopa »husets vin« stopp för okritisk empirisk användning av cefuroxim

Lakartidningen

Volumn 106, Issue 5, 2009, Pages 291-292

  Hanberger, Håkan ^a   Odenholt, Inga ^b   Giske, Christian G ^c   Kahlmeter, Gunnar ^d  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM; CEFUROXIME;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL PRACTICE; HUMAN; MICROBIOLOGICAL EXAMINATION; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CEFUROXIME; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PHYSICIAN'S PRACTICE PATTERNS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS;

EID: 61449246747     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in non-hospitalized patients. Eur J Clin Microbiol Infect Dis. 2004;23:163-7.
2. Calbo E, Romani V, Xercavins M, Gomez L, Vidal CG, Quintana S, et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother. 2006;57:780-3.
3. Wiström J, Norrby SR, Myhre EB, Eriksson S, Granström G, Lagergren L, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother. 2001;47:43-50.
4. Klugman KP. Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections. Eur Respir J Suppl. 2002;36:3s-8s.
5. Seral C, Suárez L, Rubio-Calvo C, Gómez-Lus R, Gimeno M, Coronel P, et al. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain. Diagn Microbiol Infect Dis. 2008;62:210-5.
6. Alhambra A, Cuadros JA, Cacho J, Gómez-Garcés JL, Alós JI. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics. J Antimicrob Chemother. 2004;53:1090-4.
7. Referensgruppen for antibiotikafrågor 2008. RAFs rationaldokument: Cefuroxim [citerat 2008-12-18]. http://www.srga.org/ABSPEC/Rationale-cefuroxim. pdf/